Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Functional gastrointestinal disorders (FGIDs) account for at least 40% of all referrals to gastroenterologists. Of the 33 recognized adult FGIDs, irritable bowel syndrome (IBS) is the most prevalent, with a worldwide prevalence estimated at 12%. IBS is an important health care concern as it greatly affects patients’ quality of life and imposes a significant economic burden to the health care system. Cardinal symptoms of IBS include abdominal pain and altered bowel habits. The absence of abdominal pain makes the diagnosis of IBS untenable. The diagnosis of IBS can be made by performing a careful review of the patient’s symptoms, taking a thoughtful history (e.g., diet, medication, medical, surgical, and psychological history), evaluating the patient for the presence of warning signs (e.g., “red flags” of anemia, hematochezia, unintentional weight loss, or a family history of colorectal cancer or inflammatory bowel disease), performing a guided physical examination, and using the Rome IV criteria. The Rome criteria were developed by a panel of international experts in the field of functional gastrointestinal disorders. Although initially developed to guide researchers, these criteria have undergone several revisions with the intent of making them clinically useful and relevant. This monograph provides a brief overview on the development of the Rome criteria, discusses the utility of the Rome IV criteria, and reviews how the criteria can be applied clinically to diagnose IBS. In addition, a diagnostic strategy for the cost-effective diagnosis of IBS will be reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the diagnostic criteria for functional somatic disorders usually do not require that the symptoms cause distress”
From Persistent physical symptoms: definition, genesis, and management (2024) · cites this paper as [33]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“the Rome IV criteria for irritable bowel syndrome describe only clear patterns of abdominal pain and altered bowel habits”
From Persistent physical symptoms: definition, genesis, and management (2024) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244 · cited 3×
“Bristol stool types 1 and 2 or types 6 and 7 are considered abnormal [12].”
BackgroundMethodInfluentialLacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Self-citationFunctional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440 · cited 1×
“The revised Rome II criteria were published in 1999 [5].”
MethodTowards positive diagnosis of the irritable bowel.
Manning, A. P., Thompson, W. G., Heaton, K. W., & Morris, A. F. (1978) · BMJ · doi:10.1136/bmj.2.6138.653 · Cited by 1,374
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
Palsson, O. S., Whitehead, W. E., van Tilburg, M. A. L., Chang, L., Chey, W., Crowell, M. D., Keefer, L., Lembo, A. J., Parkman, H. P., Rao, S. S. C., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.014 · Cited by 719
Ford, A. C., Lacy, B. E., & Talley, N. J. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1607547 · Cited by 587
Self-citationLagattolla, N. (2002) · Key Topics in General Surgery · doi:10.1201/b14719-46 · Cited by 521
Tibble, J. A., Sigthorsson, G., Foster, R., Forgacs, I., & Bjarnason, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.34755 · Cited by 441 · cited 1×
“The diagnostic accuracy of the Rome I criteria was evaluated in a study of 339 IBS patients with a reported sensitivity of 85% and a specificity of 71% [4].”
MethodFord, A. C., Quigley, E. M. M., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Moayyedi, P. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.148 · Cited by 405 · cited 1×
“This should improve visceral pain and may slow colonic transit to some degree [19].”
BackgroundSelf-citation
Cited by
Items 301–400 of 582
Zhang, Q., Wu, X., Wang, J., Miao, J., Li, C., Li, S., He, N., & Song, J. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10839-1 · Cited by 8
“According to the latest Rome IV criteria, IBS can be classified as constipated (IBS-C), diarrhea (IBS-D), mixed (IBS-M), and undifferentiated (IBS-U) [160].”
Self-reported Nonceliac Gluten Sensitivity in Patients With Irritable Bowel Syndrome
Brindicci, V. F., Cristofori, F., Franceschini, S., Gnasso, I., Alcini, P., Tassi, E. A., Santarelli, L., Dargenio, V. N., Castellaneta, S. P., Francavilla, R., et al. (2026) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000002306 · Cited by 3
Xu, X.-Y., Zhang, S., Hu, C.-C., Wang, Y., Tang, Y., & Wang, Y. (2026) · Food & medicine homology. · doi:10.26599/fmh.2027.9420148 · Cited by 5
Alhuzaim, W. M., Alojayri, A. M., Albednah, F. A., Alshehri, F. F., Alomari, M. A. S., Alyousef, M. A., & Alsubaie, N. E. (2022) · Cureus · doi:10.7759/cureus.31983 · Cited by 3
Barassi, G., Pirozzi, G. A., Iorio, A. D., Pellegrino, R., Galasso, P., Heimes, D., Praitano, B., Gallenga, P. E., Prosperi, L., Moccia, A., et al. (2024) · Medicina · doi:10.3390/medicina60071099 · Cited by 6
“The BSFS appears to be effective for identifying subforms of IBS such as IBS-C (grades 1 and 2) and IBS-D (grades 5, 6 and 7) according to the Rome IV Criteria [4].”
BackgroundMethodInfluentialIsmaiel, A., Foucambert, P., Ismaiel, M., Leucuta, D., Popa, S., Băban, A., & Dumitrascu, D. L. (2024) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm23159 · Cited by 5
Uriot, O., Deschamps, C., Scanzi, J., Brun, M., Kerckhove, N., Dualé, C., Fournier, E., Durif, C., Denis, S., Dapoigny, M. C., et al. (2025) · Bioengineered · doi:10.1080/21655979.2025.2458362 · Cited by 3
Sahu, S., Varshney, A., Chaudhary, M., Ghoshal, U., & Ghoshal, U. C. (2025) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm24010 · Cited by 3
“15 Furthermore, there is very little information available regarding whether IBS-like symptoms among UC patients are better or worse than IBS patients.”
The Evolution of Irritable Bowel Syndrome as a Group of Organic Diseases: A Narrative Review
Saidara, E., Barlow, G. M., & Pimentel, M. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2549381 · Cited by 3
“Established in 1992, the Rome Criteria were estimated to have a diagnostic sensitivity of 85% and a specificity of 71% [15,17].”
InfluentialIrritable bowel syndrome in view of the rome IV criteria (2016)
Dicheva, D. T., Андреев, Д. Н., Scheglanova, M. P., & Парцваниа-Виноградова, Е. В. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-3-60-66 · Cited by 8
Differential Diagnosis of Acute Diarrhea
Lee, C. S. (2021) · The Journal for Nurse Practitioners · doi:10.1016/j.nurpra.2021.10.012 · Cited by 3
Gastric Bacterial Flora in Patients with Helicobacter Pylori Infection with and without Dyspepsia
Kabil, S. M., ali, A. M., Ghazy, A. A., & Shewi, M. E. (2022) · Benha Medical Journal · doi:10.21608/bmfj.2022.119945.1540 · Cited by 2
Ghosh, S., & Sharma, J. (2023) · Cureus · doi:10.7759/cureus.38567 · Cited by 4
Dietary intake of phytochemicals in association with irritable bowel syndrome in adults
Lari, A., Shidfar, F., Aminianfar, A., Keshteli, A. H., Esmaillzadeh, A., Adibi, P., & Mehravar, F. (2023) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2023.06.013 · Cited by 4
Belogianni, K., Seed, P. T., & Lomer, M. C. E. (2023) · European Journal of Clinical Nutrition · doi:10.1038/s41430-023-01306-7 · Cited by 4
“, coeliac disease, inflammatory bowel disease, cancer) [2].”
Agwa, R. H., Alharthi, Z. S., Alzahrani, A. T., Alghamdi, M. A., Alzahrani, R. A., Alghamdi, A. A., Alghamdi, R. H., Alghamdi, S. R., & Alghamdi, A. A. (2023) · Cureus · doi:10.7759/cureus.44077 · Cited by 6
“The Rome IV criteria are now the most widely used method for diagnosing IBS without the requirement of any biochemical markers; nevertheless, to use this method, it is necessary to rule out any potential warning indications [3,4].”
Sarofim, M., Slaar, A., Dermout, S., den Boer, F. C., & Engel, A. F. (2024) · Colorectal Disease · doi:10.1111/codi.16862 · Cited by 3
GAMBARAN KEJADIAN KONSTIPASI PADA BAYI USIA 6-12 BULAN
Andriyani, A., & Agustina, L. (2023) · JURNAL KESEHATAN MASYARAKAT DAN LINGKUNGAN HIDUP · doi:10.51544/jkmlh.v8i2.4644 · Cited by 3
Daher, M., Abbas, S., Asaad, Z., Khalil, K., & Jadid, G. (2024) · Brain and Behavior · doi:10.1002/brb3.3445 · Cited by 3
“Irritable bowel syndrome (IBS) is the most common functional gastrointestinal disorder (Lacy & Patel, 2017).”
BackgroundPolycystic Ovary Syndrome and Irritable Bowel Syndrome: Is There a Common Pathway?
Naz, M. S. G., Ghasemi, V., Amirshekari, S., & Tehrani, F. R. (2024) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.477 · Cited by 6
“The symptoms started 6 months prior to the diagnosis, and they should have persisted for 3 months at this point [10].”
BackgroundGut Microbiota Dysbiosis and Its Role in the Development of Irritable Bowel Syndrome
Saleem, M. T., Masood, S., Rahmatullah, M., Imdad, I. A., Sange, A. M. A., & Nasr, D. S. (2025) · Cureus · doi:10.7759/cureus.83084 · Cited by 8
“A balanced gut microbiome is essential for the normal development and function of the intestinal immune system and also supports general GI function, barrier integrity, and modulation of permeability [14].”
Akbayram, H. T. (2021) · Turkish Journal of Family Medicine & Primary Care · doi:10.21763/tjfmpc.970954 · Cited by 3
Mittal, A. R. S., Gupta, S., Afridi, F., Dimitrey, A., & Ahlawat, S. (2022) · Cureus · doi:10.7759/cureus.25137 · Cited by 3
Ferents, I. M., Bychkova, S. V., & Bychkov, M. A. (2020) · Wiadomości Lekarskie · doi:10.36740/wlek202003133 · Cited by 3
“IBS according to Rome Criteria IV is defined as a chronic functional bowel disorder characterized by recurrent abdominal pain, which occurs and continues at least once a week for the last three months, associated with bowel movements, changes in frequency and consistency of the stool [5].”
MethodKim, B., Jo, H.-G., & Lee, D. (2020) · EXPLORE · doi:10.1016/j.explore.2020.09.004 · Cited by 3
Bhandari, A., & Chaudhary, A. (2021) · Journal of Nepal Medical Association · doi:10.31729/jnma.7070 · Cited by 4
Alfaqih, O. Y., Alnashri, Y., Alharbi, M. M., Babateen, O., Elhefny, M., Saati, A. A., Sarhan, A. A., & Iesa, M. A. M. (2022) · Medical Science · doi:10.54905/disssi/v26i127/ms365e2378 · Cited by 3
Psychogastroenterology of disorders of intestinal-brain interaction. Review with own research
Gubska, O., & Prykashchykova, H. I. (2023) · Modern Gastroenterology · doi:10.30978/mg-2023-3-61 · Cited by 7
Nursing management of irritable bowel syndrome
Coutts, A. (2019) · Nursing Standard · doi:10.7748/ns.2019.e11363 · Cited by 4
Polishchuk, S., & Neverovskyi, A. (2023) · GASTROENTEROLOGY · doi:10.22141/2308-2097.57.2.2023.540 · Cited by 3
Abdullah, N., Kueh, Y. C., Kuan, G., Wong, M. S., Tee, V., Alang, T. A. I. T., Hamid, N., & Lee, Y. Y. (2024) · PeerJ · doi:10.7717/peerj.17265 · Cited by 2
“Besides, Lacy & Patel (2017) reported that more than half of the irritable bowel syndrome (IBS) patients complained about reducing daily activities due to AB.”
BackgroundInfluentialLiu, H., Cheng, K., Lu, Y., Cabral, H., & Weber, H. C. (2025) · Diseases · doi:10.3390/diseases13050161 · Cited by 3
“…(IBS) is a highly prevalent disorder of gut–brain interaction (DGBI), previously termed functional gastrointestinal disorders (FGIDs), which manifests through recurring episodes of abdominal pain associated with altered bowel habits in the absence of organic or structural abnormalities [1–3].”
InfluentialHillman, E. B. M., Baumgartner, M., Carson, D., Amos, G. C. A., Wazir, I., Khan, H. A., Khan, M. A., Rijpkema, S. G. T., Walters, J. R. F., Wellington, E. M. H., et al. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70075 · Cited by 4
Salmela, E., Kurppa, K., Lindfors, K., Saavalainen, P., Huhtala, H., Kaukinen, K., & Taavela, J. (2025) · European Journal of Clinical Nutrition · doi:10.1038/s41430-025-01641-x · Cited by 3
“The gastrointestinal symptoms were systematically assessed to evaluate potential ful fi llment of the Rome IV criteria for IBS [12].”
Yuan, P., Nash, M., Li, T., Mahurkar‐Joshi, S., Sohn, J., Khandadash, A., Taché, Y., & Chang, L. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70199 · Cited by 3
Wang, C., Ying, Z., Zhou, R. L., Luo, Y., Lin, T., Shen, M., & Wu, J. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-094294 · Cited by 3
“30 Overall, these findings support previous literature on the influence of demographic characteristics on KAP scores in patients with FGIDs.”
Piccirillo, M., Renzi, E., Vito, C. D., Mennini, M., Giarrusso, G., Gallo, G., Quatrale, G., Bianchi, M., Graziani, M., Caron, F., et al. (2025) · Microorganisms · doi:10.3390/microorganisms14010023 · Cited by 3
“Patients with IBS-M experience more than 25% of bowel movements as types 1 or 2 and more than 25% as types 6 or 7 [16].”
Chojnacki, C. J., Mędrek-Socha, M., Chojnacki, J., Gąsiorowska, A., Walecka‐Kapica, E., Bijak, M., Przybyłowska-Sygut, K., & Popławski, T. (2026) · Nutrients · doi:10.3390/nu18010174 · Cited by 3
“Based on symptom variability and the lack of correlation between pain and defecation, patients were diagnosed with the unclassified subtype of irritable bowel syndrome (IBS-U) according to Rome IV Criteria [26,27].”
Alam, M., Abbas, K., Khan, M., Saini, R. S., & Faraz, M. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02317-8 · Cited by 2
Chronic Ocular Surface Pain: A Missing Member of the Chronic Overlapping Pain Conditions?
Chang, J., Hattenhauer, A., Saccaro, L., Mamatkazina, F., Felix, E. R., Lott, L. B. D., & Galor, A. (2026) · Drugs · doi:10.1007/s40265-026-02343-9 · Cited by 2
“…Pain Society Pain Taxonomy (AAPT) 2019 [126] and the American College of Rheumatology (ACR) 2016 criteria for FM [120]; Rome IV for IBS [127]; the International Classification of Headache Disorders 3rd Edition (ICHD-3) for migraine [128]; and the Diagnostic Criteria for…”
Gembe, A. M. (2020) · Gastroenterology & Hepatology Open Access · doi:10.15406/ghoa.2020.11.00439 · Cited by 2
Zaki, M. E. S., Elhammady, D., Salama, M. F., Abdelsalam, M., & Osman, A. O. B. (2021) · F1000Research · doi:10.12688/f1000research.52086.4 · Cited by 6
“1,2 IBS mainly manifests in abdominal pain with bowel habit changes in the absence of either radiological evidence of associated pathological conditions or detectable chemical and physiological abnormalities.”
Increased vitamin D binding protein levels are associated with irritable bowel syndrome
Börekçi, E., Kılıç, M., Ozan, Z. T., Börekçi, H., Yıldırım, T., Göçmen, Y., & Baş, H. (2021) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2020-0305 · Cited by 3
“There is no reliable and valid biomarker for the recognition of IBS and its subtypes [6].”
BackgroundNicolson, K. P., & Gillespie, G. (2022) · InnovAiT Education and inspiration for general practice · doi:10.1177/17557380211073165 · Cited by 2
“IBS can also be associated with abdominal bloating, constipation, diarrhoea, or both (Lacy and Patel, 2017).”
BackgroundSayuk, G. S., North, C. S., Pollio, D. E., Gott, B. M., & Alpers, D. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.892313 · Cited by 2
“”’; (3) extended memory, “refers to an extended period of time which lastedmore than one day, e.”
BackgroundMethodInfluentialQiu-ping, L. U. O., KUANG, S.-S., Xiao-fang, Y. A. N. G., Jin, L., Pan-bi, C. H. E. N., Yi, C. H. E. N., & Wen-rui, F. A. N. (2023) · 世界针灸杂志:英文版 · doi:10.1016/j.wjam.2023.02.003 · Cited by 2
Should gastroenterologists prescribe cannabis? The highs, the lows and the unknowns
Samuel, S. B., Michael, M., & Tadros, M. S. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i18.4210 · Cited by 2
Saké, K., Kpossou, A. R., Alassani, A. C., Nzekou, D. B. M., Adè, S., Attinsounon, C. A., Dovonou, C. A., de Tove, S. S., & Séhonou, J. (2023) · Open Journal of Gastroenterology · doi:10.4236/ojgas.2023.137024 · Cited by 3
Prevalence and severity of abdominal bloating in patients with gastroesophageal reflux disease
Shacker, M., Latorre‐Rodríguez, A. R., & Mittal, S. K. (2023) · Diseases of the Esophagus · doi:10.1093/dote/doad058 · Cited by 2
Gajjar, D., Thakkar, J., Patel, P. K., & Sagar, S. R. (2024) · Phytochemistry Reviews · doi:10.1007/s11101-024-09970-8 · Cited by 2
“Thus, there is a direct link between psychiatric comorbidities and changes in gut flora that cause IBS (Barbara et al. 2016; Park et al. 2011; Lacy and Patel 2017; Kruis et al. 1984; Thompson et al. 1999; Longstreth et al. 2006).”
Does irritable bowel syndrome plague our budding doctors? – A study from an Indian medical college
Banerjee, S., Abraham, L. M., Gopakumar, R., Harithasree, L., Chauhan, H., Holla, R., Sardesai, A., & Achappa, B. (2024) · Journal of Education and Health Promotion · doi:10.4103/jehp.jehp_1290_23 · Cited by 3
“[5] The Rome III criteria can be used to establish a diagnosis of IBS in any healthy individual who is below 50 years of and fulfills the criteria, hence may require minimal to no diagnostic testing.”
MethodBelogianni, K., Khandige, P., Silverio, S. A., Windgassen, S., Moss-Morris, R. E., & Lomer, M. C. E. (2024) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2024.07.169 · Cited by 2
Microbiome-Based Treatment for Gastrointestinal Tract Disorders
Abbas, S., Khan, A., Akhter, T. S., Samad, A., Chinnam, S., Mushtaq, S., Usman, M., Khan, A., & Akash, M. S. H. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_12 · Cited by 3
Patel, R. M., & Wong, D. J. (2024) · Internal Medicine Journal · doi:10.1111/imj.16586 · Cited by 4
Barros, L. L., Leite, G., Morales, W., Barlow, G. M., de Azevedo, M. F. C., Carlos, A. D. S., Damião, A. O. M. C., Pimentel, M., & Farias, A. Q. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03509-z · Cited by 3
Drug Survival of Drugs Recommended for Irritable Bowel Syndrome: A Retrospective Observational Study
Sandberg‐Janzon, A., & Karling, P. (2025) · Neurogastroenterology & Motility · doi:10.1111/nmo.70063 · Cited by 2
“symptom onset occurring at least 6 months before the diagnosis [5].”
Mattioli, L., Budriesi, R., Camarda, L., Nardi, E., Rossi, P. L., BONDIOLI, L., & Corazza, I. (2025) · Journal of Mechanics in Medicine and Biology · doi:10.1142/s0219519425400512 · Cited by 3
Kang, C.-Y., Lim, J.-Y., Lee, E., Lee, Y., Choi, W.-H., & Yu, H. (2025) · Medicine · doi:10.1097/md.0000000000043541 · Cited by 2
“[11] For hypertension, blood pressure was checked every Monday, using the first reading of the day before hemodialysis.”
Prospects for the use of biomarkers in the diagnosis of irritable bowel syndrome
Ахмедов, В. А., Sargsyan, A. K., & Gaus, O. V. (2020) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-175-3-94-101 · Cited by 2
Heart rate variability and trait anxiety in children with irritable bowel syndrome: is there a link?
Semen, M. O., Lychkovska, O. L., Semen, V. D., & Yelisyeyeva, O. P. (2022) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2022.5.256942 · Cited by 2
Traditional Ayurveda Medicines for the Management of Amlapitta (Functional Dyspepsia)
Yadav, B., Mahajon, B., Dubey, N., Panda, A. K., Rao, B. C. S., Singhal, R., & Srikanth, N. (2019) · Journal of Research in Ayurvedic Sciences · doi:10.5005/jras-10064-0080 · Cited by 2
Трухан, Д. И., Degovtsov, E. N., & Дрокина, О. В. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-5-142-153 · Cited by 2
Effects of coronavirus disease 2019 on the digestive system and its nutritional implications
Aguila, E. J. T., Cua, I. H. Y., & Singh, R. (2021) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000785 · Cited by 2
“IBS is a common functional GI disorder characterized as recurrent abdominal pain that is associated with a change in consistency or frequency of stools [50].”
BackgroundIrritable bowel syndrome among medical students and its association with anxiety.
Shafique, S., Faraz, N., Wasti, H., & Surti, A. (2021) · The Professional Medical Journal · doi:10.29309/tpmj/2021.28.11.6326 · Cited by 3
Buspirone in the management of refractory irritable bowel syndrome: A case report
Karim, M. A., Al-Baz, N., Haddad, P. M., Reagu, S. M., & Alabdulla, M. (2021) · Medicine · doi:10.1097/md.0000000000028003 · Cited by 3
“change in stool form.([13]) In addition, criteria must be fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis.”
Emerging therapies in the management of Irritable Bowel Syndrome (IBS)
Elwing, J. E., Atassi, H., Rogers, B. D., & Sayuk, G. S. (2022) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2022.2052043 · Cited by 2
“’[2] Further, the symptoms should occur in the absence of any organic gastrointestinal (GI) diagnosis, such”
BackgroundCurrent Prospects of Rome Criteria for the Diagnosis of Irritable Bowel Syndrome
Shammout, R. Z., & Ahmad, M. N. (2022) · Jordan Journal of Agricultural Sciences · doi:10.35516/jjas.v18i1.105 · Cited by 2
“Patients with the mixed subtype of alternating constipation and diarrhea (IBS-M) have >25% of their bowel movements associated with BSFS 1 or 2 and >25% of their bowel movements associated with BSFS 6 or 7 (Lacy and Patel, 2017; Ford et al., 2020).”
BackgroundFunctional gastrointestinal disorders and nutritional status in junior high school students
Alatas, F. S., Salsabila, K., Nadira, Amalia, N., & Hanafi, G. (2022) · Paediatrica Indonesiana · doi:10.14238/pi62.4.2022.243-8 · Cited by 2
Hamblin, H. S., Gunaratne, A. W., Clancy, A. K., Pilarinos, D., Busque, A. L., Dawson, M. V. M., & Borody, T. J. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/6083896 · Cited by 3
“Unsurprisingly, participants diagnosed with IBS-D reported significantly greater severity in stool urgency (median score = 3, range 0–6) compared to participants with IBS-C (median score = 1, range 0–5; p = 0:03), whilst participants with IBS-C reported a significantly lower number of daily bowel motions (median score…”
MethodInfluentialTopic: Nutrition and the Gut-Liver-Brain Axis
Ho, A. H. Y., Wong, S. H., & Lui, R. N.-S. (2022) · Current Hepatology Reports · doi:10.1007/s11901-022-00589-x · Cited by 3
Alshammari, S. A., Almutairi, M. N., Alomar, M. O., Alsherif, Z. M., Alsubaie, F., & Almezaini, A. I. (2023) · Cureus · doi:10.7759/cureus.50840 · Cited by 3
“The study utilized a structured questionnaire, which comprised four sections, including personal and demographic information, the Rome IV criteria for the IBS diagnosis tool [19], and the GERD quality of life tool [20].”
MethodA Novel Vibrating Capsule Treatment for Constipation: A Review of the Literature
Uwawah, T. D., Nduma, B. N., Nkeonye, S., Kaur, D., & Ekhator, C. (2024) · Cureus · doi:10.7759/cureus.52943 · Cited by 5
“Particularly, as many as 47% of constipated patients have been asserted not to be completely satisfied with their current treatments for constipation, hence a growing pattern in the interest in new therapies [9].”
BackgroundGerasimets, E. A., Rumyantsev, N. A., Ilin, R. S., & Goryachev, D. V. (2024) · Ведомости Научного центра экспертизы средств медицинского применения · doi:10.30895/1991-2919-2024-14-4-463-473 · Cited by 2
Definition of Irritable Bowel Syndrome
Kamiya, T., & Shikano, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-8410-3_1 · Cited by 5
Mohamed, N., Khalid, H., Abdullah, K., Ramadan, N., Alzuhairi, R., Alqurashi, R. S., & Hasnaoui-Saadani, R. E. (2019) · International Journal of Sciences: Basic and Applied Research · Cited by 2
Li, H., Chen, Y., Hu, Z., Yi, Y., Ye, J., Zhou, Y., Yu, Z., & Tang, H. (2021) · Medicine · doi:10.1097/md.0000000000025604 · Cited by 2
Mengistu, S. B., Asnakew, M. M., Eskinder, M., Sisay, M., Zewdu, M., Mamo, M., Mulugeta, M., & Gebrehana, A. W. (2024) · Research Square · doi:10.21203/rs.3.rs-4423523/v1 · Cited by 2
Irritable Bowel Syndrome Among University Students in JordanPreprint
Al-Shdaifat, A., Al-Kassar, A., Johannessen, A., Al-Dabbagh, Z., Al-Ethawi, M., Al-Obaidi, F., & El-Halabi, I. (2019) · Research Square · doi:10.21203/rs.2.11508/v1 · Cited by 2
“It is characterized by abdominal pain or discomfort, associated with altered bowel habits, in the absence of specific and unique organic pathology (1).”
BackgroundAbdullah, N., Kueh, Y. C., Kuan, G., Yahaya, F. H., & Lee, Y. Y. (2022) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2022.29.6.8 · Cited by 1
Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
Shaikh, O. A., Shaikh, G., Aftab, R. M., Baktashi, H., Ullah, I., & Asghar, M. S. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000000338 · Cited by 1
“There is also the Rome IV criteria, which is a modified approach to Rome III, adding that the repetitive abdominal pain must appear on an average of a minimum of 1 day throughout the week in the previous 3 months and may be in association with defecation, that is either increasing or remaining unchanged by defecating(…”
Lancsek, L., Faber, S. M., Rutledge, C., Maduro, R. S., Morgan, M. K., & Zimbro, K. S. (2023) · Journal of Nursing Care Quality · doi:10.1097/ncq.0000000000000725 · Cited by 1
Jafari, S., & Joharifard, R. (2023) · مجله علمی دانشگاه علوم پزشکی رفسنجان · doi:10.52547/jrums.22.3.4 · Cited by 10
Трухан, Д. И., Degovtsov, E. N., Goloshubina, V. V., & Popilov, M. A. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2023-284 · Cited by 1
Evaluation of Sexual Function in Egyptians with Irritable Bowel Syndrome: A Case-Control Study
Mahran, A., Sabry, A., Ghadour, A. A., Ibrahiem, I. A., & Hosny, A. (2024) · International Journal of Medical Arts · doi:10.21608/ijma.2024.290326.1973 · Cited by 1
“…criteria, which define IBS as abdominal discomfort occurring at least once per week on average for the past three months, and meeting two of the following criteria: related to defecation, correlated with an alteration in stool consistency, and correlated with an alteration in stool frequency [12] .”
BackgroundRakesh, D., JADHAV†, D. L. L., Gopan, Y., KJ, D. G., MUTTAPPA, D. T., & B, D. V. (2024) · Indian Journal Of Clinical Practice · doi:10.59793/ijcp.v35i3.1087 · Cited by 1
Psychometric Evaluation of the Abdominal Bloating Social Support Scale
Abdullah, N., Cheng, K. Y., Kuan, G., Wong, M. S., & Yeh, L. Y. (2024) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2024.31.4.11 · Cited by 1
Lang, P. A., Thomas, L., & Lidbury, B. A. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08629-w · Cited by 2
“In addition to the MMPI-2-RF and health and wellness questionnaire, participants were required to complete the Rome Criteria [23] to assess the presence and/or impact of IBS symptoms at the time of investigation.”
General concept of somatization
Grover, S., & Naskar, C. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780192858290.003.0002 · Cited by 1
Fecal calprotectin levels in patients with fibromyalgia: A cross-sectional study
Çınar, E., Aytar, M. B. T., Baklacı, M., Hepgüler, S., & Barutçuoğlu, B. (2024) · Archives of Rheumatology · doi:10.46497/archrheumatol.2024.10557 · Cited by 1
“13 In some cases, addition of new symptoms indicating underlying organic disease may be disregarded or unrecognized in a patient with FMS, particularly if these symptoms have been present for a long time and were previously associated with IBS.”
Shoaib, M., Haq, E. U., Khan, M. A., Khattak, S., Akbar, H., Khan, S. A., & Irfan, S. (2025) · Pakistan BioMedical Journal · doi:10.54393/pbmj.v8i3.1221 · Cited by 2
Fowler, S., Paech, G. M., Hoedt, E. C., Pryor, J. C., Nieva, C., Bruce, J. K., Nair, P. M., Eslick, G. D., Sherwin, S. K., Pockney, P. G., et al. (2025) · Experimental Physiology · doi:10.1113/ep092725 · Cited by 1
Srivastava, A. K., Singh, A., Yadav, D. P., Nath, G., & Ganju, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34039-0.00009-3 · Cited by 1
Yeshitila, E. T., Aliye, N. J., Nur, A. M., & Yilma, M. (2025) · BMC Gastroenterology · doi:10.1186/s12876-025-04415-8 · Cited by 2
Prospero, L., Riezzo, G., Laselva, G., D’Attoma, B., Ignazzi, A., Goscilo, F., Bianco, A., Franco, I., Verrelli, N., Bagnato, C. B., et al. (2025) · Frontiers in Psychology · doi:10.3389/fpsyg.2025.1709017 · Cited by 3
“To meet these criteria, patients reported recurrent abdominal pain occurring at least 1 day per week over the past 3 months, along with at least two of the following: pain related to defecation, changes in stool frequency, or changes in stool form (Lacy and Patel, 2017).”
Levine, J. J., Thomas, S. C., Xu, F., Isbiroglu, A., Zanganeh, R., Barazani, L., Vardhan, M., Hwang, S., Persaud, J. K., Thakor, N., et al. (2026) · Physiological Reports · doi:10.14814/phy2.70665 · Cited by 1
“Our DGBI group consisted of newly diagnosed and treatment-naïve patients who met diagnostic criteria for a functional gastrointestinal disorder according to Rome criteria (Lacy & Patel, 2017).”
Guney-Coskun, M., Sarıkaya, B., Kolay, E., & Yiğit, A. (2026) · Nutrition Reviews · doi:10.1093/nutrit/nuaf294 · Cited by 1
Ajabnoor, S. M., & Tashkandi, L. (2026) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_454_25 · Cited by 1
“[12] IBS is categorized into subtypes based on bowel habit changes: constipation-predominant (IBS-C), diarrhea-predominant (IBS-D), mixed (IBS-M), and unclassified (IBS-U).”
InfluentialDuong, M. A., & Ramdass, P. V. A. K. (2026) · Biomedicines · doi:10.3390/biomedicines14091891 · Cited by 1
“Similarly, IBS is one of the most prevalent disorders of gut–brain interaction, affecting an estimated 5–10% of the global population and presenting with recurrent abdominal pain, altered bowel habits, bloating, and visceral hypersensitivity [3,4].”
Balmuș, I.-M., Ciobica, A. S., Cojocariu, R. O., Gorgan, L., Stanciu, C., & Trifan, A. V. (2019) · E-Health and Bioengineering Conference (EHB) · doi:10.1109/ehb47216.2019.8970036 · Cited by 2
“Gastrointestinal habits survey consisted in 5 “yes/no” answer items, based on Rome IV Diagnostic Criteria for IBS [10].”
MethodExamination of Nonpharmacological Method Uses of Patients with Irritable Bowel Syndrome
Aktaş, Ü., & Kıyak, E. (2020) · Ankara Medical Journal · doi:10.5505/amj.2020.35403 · Cited by 2
Metadata
- Authors
- Lacy, B., & Patel, N.
- Affiliations
- Dartmouth–Hitchcock Medical Center (US)
- Corresponding author
- Patel, Nihal
- ORCID
- Lacy, Brian
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2017-10-26
- Volume
- 6
- Issue
- 11
- Pages
- 99
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC5704116
- OpenAlex
- W2766963630
- Semantic Scholar
- b33dc825c1d24803a560443b65c3158fbf3991dd
- Cited by
- 575
- References
- 22
- Citations by year
- 2026: 46 · 2025: 72 · 2024: 85 · 2023: 104 · 2022: 74 · 2021: 79 · 2020: 58 · 2019: 43 · 2018: 14
- FWCI
- 33.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Infant Health and Development
- Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
- Keywords
- irritable bowel syndrome, Rome IV criteria, functional gastrointestinal disorders, IBS diagnosis, diagnostic criteria, abdominal pain, altered bowel habits, red flags, clinical history taking, cost-effective diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.